+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tobramycin"

From
Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Aminoglycosides Market Report 2025 - Product Thumbnail Image

Aminoglycosides Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Inhaled Antibiotics Market Report 2025 - Product Thumbnail Image

Inhaled Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Tobramycin Eye Drop Global Market Report 2024 - Product Thumbnail Image

Tobramycin Eye Drop Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Tobramycin is an aminoglycoside antibiotic used to treat a variety of bacterial infections. It is commonly used to treat respiratory tract infections, urinary tract infections, and skin and soft tissue infections. Tobramycin is also used to treat certain types of meningitis and sepsis. It is usually administered intravenously or intramuscularly, and is available in both generic and branded forms. Tobramycin is a widely used antibiotic, and is often used in combination with other antibiotics to treat more serious infections. It is generally well tolerated, with few side effects. However, it can cause nephrotoxicity and ototoxicity, and should be used with caution in patients with renal impairment. The tobramycin market is highly competitive, with a number of companies offering branded and generic versions of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and Mylan. Show Less Read more